Glimmer of a Silver Lining in Latest Alzheimer's Trial
Friday, August 24, 2012 - 16:30
in Health & Medicine
The anti-amyloid therapy solanezumab may slow cognitive decline in people with mild disease
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via